Cordacare contains an active substance lisinopril and belongs to a group of medicines called ACE inhibitors (angiotensin converting enzyme inhibitors). Inhibition of ACE leads to decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion.


Cordacare is indicated for:
– treatment of arterial hypertension;
– treatment of heart failure;
– treatment of haemodynamically stable patients within 24 hours after an acute myocardial infarction as a precaution against left ventricular dysfunction;
– treatment of renal disease in hypertensive patients with type 2 diabetes mellitus and incipient nephropathy.

Subject to medical prescription.

Concentration and pharmaceutical form: 10 mg, 20 mg tablets